Cargando…
ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries
The biopharmaceutical classification system (BCS) is a very important tool to replace the traditional in vivo bioequivalence studies with in vitro dissolution assays during multisource product development. This paper compares the most recent harmonized guideline for biowaivers based on the biopharma...
Autores principales: | Miranda, Claudia, Aceituno, Alexis, Fernández, Mirna, Mendes, Gustavo, Rodríguez, Yanina, Llauró, Verónica, Cabrera-Pérez, Miguel Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001157/ https://www.ncbi.nlm.nih.gov/pubmed/33801796 http://dx.doi.org/10.3390/pharmaceutics13030363 |
Ejemplares similares
-
Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars
por: Niazi, Sarfaraz K., et al.
Publicado: (2022) -
A Physiologically Based Pharmacokinetic Model for Studying the Biowaiver Risk of Biopharmaceutics Classification System Class I Drugs With Rapid Elimination: Dexketoprofen Trometamol Case Study
por: Zhang, Xian, et al.
Publicado: (2022) -
Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
por: Lenić, Ines, et al.
Publicado: (2019) -
Evaluation of Excipient Risk in BCS Class I and III Biowaivers
por: Metry, Melissa, et al.
Publicado: (2022) -
Interchangeability Evaluation of Multisource Ibuprofen Drug Products Using Biowaiver Procedure
por: Shohin, I. E., et al.
Publicado: (2011)